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A B S T R A C T
The increasing demand for personalized medicine necessitates the production of easily
customizable dosage forms. As the number of possible dosage forms may scale toward in-
finity, their uniqueness requires a versatile production platform and numerical simulation
in order to be manufactured efficiently. A mathematical description of these systems is the
only feasible approach to manage such diverse properties of different products. However,
experimental verification is still essential for evaluation of processability and related con-
comitant phenomena, such as possible solid state changes that may occur during production
and storage.
© 2016 Production and hosting by Elsevier B.V. on behalf of Shenyang Pharmaceutical
University. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Future manufacturing lines for pharmaceutical production will
increasingly be based on continuously operating lines that
enable flexible dosing of pharmaceuticals for personalized needs
[1]. These tailor-made medicinal products may rely on recent
innovations within genomics and diagnostics, which can be
used as an input in defining patients’ individual dosing regimes.
Conceivably also the patient’s dose may be adjusted accord-
ing to input from e.g. telemedicine devices that have online
data monitoring and can gather important biological and clini-
cal parameters such as blood plasma concentrations of the drug
compound measured [2,3]. Based on these possibilities, there
is a need for more fundamental research enabling a
manufacturing-on-demand based health-care system [4] and
drug product development based on therapy-driven target drug
delivery profiles [5].
One approach for flexible dosing is hot melt extrusion (HME)
based production that enables manufacturing of innovative
product shapes that can be easily divided into the required dose
[6,7]. The manufacturing of such dosage forms in a personal-
ized medicine scenario requires continuous monitoring of the
product in order to assure that it complies with the desired
drug loading and product consistency [1]. HME provides the pos-
sibility to process medicines into the desired size and shape
using various die geometries. Circular dies can be used for the
production of rods that can subsequently be pelletized or
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spheronized, or flat dies may be used for the production of films.
Furthermore, downstream injection molding provides an even
broader array of possible sizes and shapes of the final product
[8]. Finally, the emerging capabilities of 3D printing produc-
tion platforms provide infinite possibilities for manipulation
of the final product size and shape (limited by resolution) and
could become the leading production platform for personal-
ized medicine [9]. The recent FDA approval of SPRITAM, a 3D
printed orally dissolving tablet, further emphasizes that 3D
printing is a viable method for production of innovative drug
formulations [10].
Many pharmaceutical processes, including HME, require a
powder feed. Powder feeding into an extruder may necessi-
tate a flow in a restricted geometry similar to powder flow in
a hopper. Numerous investigations on powder flow in hoppers
and silos have been performed during the last century and
many of these investigations have been based on Janssen’s work
dating back to 1895 [11]. More recent efforts to solve the pres-
sures persisting within these loaded silo and hopper structures
by finite element modeling have also been pursued [12–16]. In
addition, HME processing typically involves production of a
molten polymer–active compound mixture, and once ex-
truded, the solid state composition of the mixture can have
an impact on the product properties, such as mechanical
strength and dissolution rate. One of the most critical quality
attributes of these products is achieving a stable solid form com-
position, and possible changes to the solid form during
processing can have a significant impact on the product quality.
As for the example shown by Young et al., hot-melt extruded
products can recrystallize from the amorphous state [17]. It is
therefore important to design the processing conditions such
that an optimal product can be produced.
In any process involving polymer melts, including HME, un-
derstanding the rheology of the polymeric excipients is of
crucial importance. Moreover, the addition of active pharma-
ceutical ingredients (APIs) can significantly affect the flow
properties of polymer melts: many small molecule APIs that
are soluble in the polymeric excipients used in HME can act
as plasticizers and thereby decrease the viscosity of the melt
compared to the pure polymer [18–21].At concentrations beyond
the solubility limit, theAPI is suspended as solid material, which
may increase the viscosity of the melt [21]. Melt flow pro-
cesses of polymers and their mixtures involve complex rheology
due to their non-Newtonian and viscoelastic behavior. Addi-
tionally, flow behavior of highly filled dispersions increases the
difficulty in prediction of the extrusion process outcome and
necessitates the understanding of the fundamental rheologi-
cal properties. Simulation of the hot melt extrusion process
can reduce costs and development time compared to trial-
and-error approaches,making it an efficient tool in the product
and process design phase and when scaling up the process for
mass production. For an accurate and reliable HME simula-
tion, material parameters such as melt density, heat transfer
properties, and viscosity as a function of temperature and shear
rate must be characterized [22].
It is often beneficial to obtain an insight into these factors
by a computational approach.Therefore, in addition to the ex-
perimental part, we report a computational approach (in silico
product design). The primary aim of the computations was to
evaluate the mechanical properties and dissolution rate of the
extrudates, and the secondary aim was to evaluate the stresses
within a hopper representing the powder feeding system for
an extruder.
2. Materials and methods
The finite element method (FEM) was utilized for the compu-
tational approach by numerical analysis. COMSOL Multiphysics
v. 4.4. (Stockholm, Sweden) was used to build the geometry of
the extrudate and powder hopper as well as to construct the
mesh and to solve the partial differential equation systems.
For the experimental approach, a model formulation con-
sisting of nitrofurantoin monohydrate and PEO was used.The
extrusion was performed on a 5 ml lab scale extruder (Xplore
micro compounder, Geleen, The Netherlands) equipped with
two co-rotating screws, three individually controlled heating
zones, and a recycling channel that enables recirculation of the
melt within the barrel. The API–polymer mixture was fed into
the hopper manually. After the desired recirculation time, the
melt was extruded through a circular die (Ø = 15 mm), and the
extrudates were cooled at room temperature.
XRPD measurements on the extrudates were performed
using an X’Pert PRO θ/θ X-ray diffractometer (PANalytical,
Almelo, The Netherlands). The diffractograms were obtained
in Bragg–Brentano reflection mode utilizing a PIXel detector
(PANalytical).The operating voltage and current were 45 kV and
40 mA, respectively. A continuous scan over 2θ was per-
formed in the range from 4 to 40°C with a step time of 96.4 s/
point and a point resolution of 0.026 °C.
NIR chemical (NIR-CI) images of the extrudates were ob-
tained with a spectrometer (Headwall Photonics model 1002A-
00371, Fitchburg, MA, USA).This NIR chemical imaging camera
is a prototype kindly provided by FOSS (FOSS A/S, Hilleroed,
Denmark). NIR chemical images of extrudates were recorded
in the wavelength range of 1100–1700 nm. The spectrometer
was adapted to a line mapping configuration with a line con-
sisting of 320 pixels. Spectra were recorded in diffuse reflectance
mode with a resolution of 50 × 312 μm/pixel.
NIR-CI data processing was performed using MATLAB 7.1
(The MathWorks, Natick, MA) software and in-house rou-
tines under the name of HYPER-Tools (freely available on
demand) together with PLSToolbox (Eigenvector Research Inc.,
Wenatchee, USA). Since the raw data from NIR-CI measure-
ment consist of information both from the sample and from
the instrument, background correction is necessary. The high
reflectance standard Spectralon™ (Labsphere, Inc., North Sutton,
NH, USA) was used as a background reference. Areas contain-
ing non-sample information were eliminated by masking.
Standard Normal Variate transformation, Savitzky–Golay
smoothing with window size of 13 and polynomial order of 2,
together with mean-centering were applied as pre-processing
methods.
Measurement of flow properties of polyethylene oxide (PEO)
was used as an example of a widely used polymeric excipi-
ent in pharmaceutical applications. PEOmelt (viscosity average
molecular weight Mv = 100.000 g/mol) was characterized in
steady state rotational shear (SS) and small angle oscillatory
shear (SAOS) at three different temperatures using an AR-G2
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stress-controlled rotational rheometer (TA Instruments, New
Castle, DE, USA) with a 25 mm parallel plate geometry. Differ-
ent viscosity models can be used to capture the flow behavior
of such polymers to enable the flow predictions for process
simulations. The Carreau–Yasuda viscosity model (Eq. (1))
η γ η λγ ( ) = + ( )⎡⎣ ⎤⎦
−
0
1
1 a
n
a (1)
was fitted to the superimposed SAOS and SS data at each tem-
perature. The model has four fitting parameters: η0 = zero-
shear viscosity, n = power-law coefficient, λ = characteristic
relaxation time, and the parameter a, which determines the
sharpness of the shift from the zero-shear to power-law region.
The fitting was performed using the non-linear fitting with
least-squares method in GraphPad Prism 6 software (La Jolla,
CA, USA), with the parameter constraints η0, λ, a < 0, and
0 < n < 1.
3. Results and discussion
3.1. In silico product design
3.1.1. Simulation of process equipment geometry
The computational approach can be utilized to design inno-
vative engineering solutions and processing equipment. One
of the remaining challenges within engineering of solid dosage
forms is the calculation of stresses within a hopper filled with
powder, such as the feeding system for an extruder (Fig. 1). Cal-
culation of stress can be used to evaluate the powder flowability
and flow patterns, i.e. to evaluate whether the system exhib-
its mass flow, funnel flow, or no flow at all. It should also be
mentioned that simulation of the heat, mixing pressure, and
material transfer in various screw elements within an ex-
truder has previously been described in the literature [22–24].
The stresses within the hopper can be calculated using mea-
sured or estimated values for Young’s modulus (e.g. 200 MPa),
density (e.g. 366 kg/m3), wall static frictional coefficient (e.g. 0.73),
and Poisson’s ratio (e.g. 0.3) (Fig. 2a and b). Based on these cal-
culations, the optimal design of the processing equipment that
accommodates acceptable stresses within the powder prior to
(Fig. 2a) and during extrusion can be identified (Fig. 2b) in order
to avoid flow problems, such as segregation, stagnant zones
and arching [25].
3.1.2. Simulation of the mechanical properties of the drug
product
The mechanical properties of extrudates, e.g. specific elastic
properties, are important attributes to control especially when
designing dosage forms that can endure handling and storage.
The mechanical properties of the final dosage form can be es-
timated computationally: The estimation requires the
construction of a 3D CAD generated structure, resembling for
instance a cross-section of an extrudate (Fig. 2c). Such a struc-
ture can subsequently be subjected to a given computational
vertical load exerted by a rigid object (reaching 2522 N). Uti-
lizing appropriate values for theYoung’s modulus (e.g. 3.2 GPa),
the density (e.g. 1190 kg/m2) and the Poisson’s ratio (e.g. 0.35)
of the mixture, the resulting deformation can be visualized
(Fig. 2d). Based on these calculations, the deformation under
a given load can be calculated using the geometry, theYoung’s
modulus, the density, and the Poisson’s ratio of the object, and
the load as input parameters. Shang et al. have previously in-
vestigated modeling of tablet breaking using the finite element
method [26].
3.1.3. Simulation of the dissolution properties of the drug
product
Dissolution rate of the given drug formulation is another rel-
evant property to investigate. Boetker et al. have previously
investigated modeling of dissolution within a UV imaging setup
[27]. Such calculations of the dissolution of the formulation
require the solubility concentration (e.g. 1 mol/m3) and
diffusivity (e.g. 1 ∙ 10−9m2/s) in a given dissolution medium as
input parameters, and the concentration change over time can
then be solved computationally (Fig. 2e).A computational evalu-
ation of the dissolution rate may be especially useful when
designing personalized medicine due to the infinite number
of possible designs that may result in different dissolution rates
of the given product. Based on these calculations, the disso-
lution rate of an object in a givenmedia can be calculated using
the geometry, the solubility concentration and the diffusivity
of the compound in the media as input parameters.
3.1.4. Potential of the in silico approach
The in silico approach facilitates the design of flexible prod-
ucts with tailor-made structures.The development of innovative
product design principles will pave the way towards person-
alized products [28]. It should be further noted that new
engineering solutions andmanufacturing innovation is needed.
The simulation based approach gives a possibility for design-
ing new products and production systems meeting the needs
of patient-centered medication.
Fig. 1 – Schematic representation of a hot-melt extruder
with hopper and barrel in dark gray. Powder in light blue
and screw in light gray.
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3.2. Experimental support for in silico product design
3.2.1. Rheological analysis
Most pure polymers are shear thinning in nature and their vis-
cosity is highly dependent on temperature. Typically three
different regions can be distinguished in their viscosity vs. shear
rate curve: zero-shear viscosityη0 (1stNewtonianplateau),where
the viscosity is independent of the shear rate; transition area
with the shift from η0 to shear thinning area; and the power-
law areawith shear thinning following the power-law function,
Fig. 2 – In silico process and product design of a hot melt extruded dosage form. (a) Rotated 2D axisymmetric
representations of stress tensor in the downward direction prior to feeding of an extruder (units are given in Pa). (b) Rotated
2D axisymmetric representations of stress tensor in the downward direction during feeding of an extruder (units are given
in Pa). (c) Design of a CAD geometry representing a cross-section of an extrudate with 10 mm Ø and a height of 2 mm. (d)
2D simulation of a deformation of the sliced extruded strand geometry under a vertical load (units are given in N/m2 and
represent the von Mises stress). (e) Simulation of the dissolution of the sliced extrudate strand geometry displaying the
concentration gradients from the tablet surface (units are given in mol/m3).
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η γs n∝ − 1 . Here, shear viscosity (ηs) decreases as a function of
shear rate ( γ ) with a constant slope (n−1), and the degree of
shear thinning is governed by the power-law coefficient, n.
The results from the SAOS and SS tests for PEO; an abso-
lute value of complex viscosity (│η*│) and shear viscosity (ηs)
vs. angular frequency (ω) and shear rate ( γ ), respectively, are
shown in Fig. 3a. The results indicate that the empirical Cox–
Merz rule [29]: η γ η ωS ( ) = ( )* , when γ ω= , is valid for PEO.The
fitted Carreau–Yasuda model (solid line in Fig. 3a) had R2 values
of 0.9991, 0.9994, and 0.9994 for the datasets of 100, 130, and
160 °C, respectively.
With a high content of undissolved API, rheological behav-
ior of the mixture is radically different from the pure polymer:
Concentrated solid dispersions often show yield stress below
which no flow occurs, and the zero-shear viscosity plateau at
low shear rates vanishes. In such a case, the Carreau–Yasuda
model cannot provide a satisfactory fit, but various models for
viscoplastic materials can describe the behavior more accu-
rately [29–31]. The effect of the API content was demonstrated
for paracetamol (PRC)–PEO system. The SAOS measurements
done at 130 °C for the hot-melt extruded mixtures show plas-
ticization with PRC content up to 50%, and an increase in
viscosity level with yield stress at low frequency for the mixture
containing 70% PRC (Fig. 3b). The results presented here dem-
onstrate the importance of the rheological characterization for
accurate predictions and realistic simulations of processes in-
volving flow of molten API–polymer systems.
3.2.2. Solid state analysis
One of the critical quality attributes for a hot melt extruded
product is the solid state characteristics of the extrudates that
may change during processing. Such changesmay not only have
a major effect on bioavailability, but also a direct impact on
the mechanical properties of the extrudates. It was observed
that nitrofurantoin monohydrate (NFMH), a typical isolated site
hydrate, dehydrates with an onset temperature around 100 °C
during a thermogravimetric analysis (TGA, theoretical weight
loss 7.0%, experimental weight loss 6.9%, data not shown).
However, as shown in Fig. 4, dehydration of NFMH to the ni-
trofurantoin anhydrate (NFAH) form is observed in the hot melt
extruded NF–PEO mixture already at an operating tempera-
ture of around 70 °C, markedly lower than the dehydration
temperature observed during a typical off-line preformulation
study performed with TGA.The degree of dehydration was de-
pendent on the recirculation time of the mixture in the hot-
melt extruder. A more pronounced dehydration occurred with
a 5 min recirculation time compared to direct extrusion (re-
circulation time 0 min), observed as reduction in the
monohydrate peak labeled * and an increase in the anhydrate
peak labeled + over time (Fig. 4).
Fig. 3 – (a) Viscosity of polyethylene oxide measured at 100, 130, and 160 °C in oscillatory (SAOS, open symbols) and steady-
state rotational shear (SS, filled symbols). The continuous line represents the Carreau–Yasuda model fitted to both SS and
SAOS data. (b) Complex viscosity (T = 130 °C) of PEO and extruded PRC:PEO mixtures at PRC content of 10, 30, 50, and 70%,
the last one showing yield stress (no plateauing toward zero-shear viscosity).
Fig. 4 – X-ray powder diffractograms displaying anhydrate
and monohydrate forms of nitrofurantoin in the extruded
products (with starting material 30:70 NFMH:PEO) with
recirculation times of 0 and 5 minutes (* and + are
characteristic diffractions of monohydrate and anhydrate,
respectively).
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3.2.3. Chemical imaging
Experimental investigations of the API distribution in the
extrudates were further explored using NIR imaging com-
bined with multivariate data analysis of the extrudates. Such
an NIR imaging setup can be employed in a process analyti-
cal technology (PAT) setup where all the products prepared are
imaged and these images may subsequently be used for
real-time release testing of the products. Other options on per-
forming PAT on hot-melt extrusion processes have previously
been investigated using Raman probes [32] and NIR probes [33].
Fig. 5 displays the NIR spectra of the starting materials; here,
it is possible to obtain data on the ratio of NFMH to PEO since
the different species exhibit non-overlaying features in their
NIR spectra.
The score surface images and loadings of PC1 and PC2 are
depicted in Fig. 6b and d, respectively. The first loading of the
PCA model (Fig. 6b) explained 71.9% of the variation and could
be correlated to the surface texture variation. The second
loading (Fig. 6d) explained 22.4% of the variation and had char-
acteristic bands at 1285, 1480 and 1520 nm. The appearance
of these bands indicates that the variation captured by prin-
cipal component 2 can be correlated to the pure spectrum of
PEO shown in Fig. 5.Therefore, variation captured by the second
loading could be related to the variation of PEO content among
the extrudates. The score surface image (Fig. 6c) also indi-
cates that extrudate A, which has a higher concentration of
PEO, also has higher score values compared to extrudate C,
which contains a lower concentration of PEO. Based on the score
surface image, it was possible to distinguish among different
extrudates as a function of PEO content that, in turn, could be
correlated to the API content. High score values are indicated
by dark red, and low score values are indicated by dark blue
color. The remaining PCs did not include additional informa-
tion and the data are not shown.The utilization of NIR imaging
in combination with multivariate data analysis may thus
provide means for the establishment of a continuous moni-
toring of the HME process, which is a prerequisite for the
production of personalized medicine.
It can be summarized that the materials science simula-
tion is capable of supporting the design of customizable dosage
forms intended for personalized medicine.The simulation ap-
proach is required to design the possibly infinite amount of
different dosage forms, and PAT is needed to control the product
quality in the future manufacturing-on-demand based health-
care scenario. Fig. 7 displays the schematic outline of the
simulation and experimental tools necessary to control and
monitor a given manufacturing process. The optimization of
API content and spatial location is needed in order to make
the product truly personalized, where it is given that each
product may contain different amounts of API and poten-
tially different APIs as a combination product. On the
experimental side, chemical imaging and especially spectro-
scopic techniques such as NIR and Raman can be used for both
qualitative and quantitative assessments of the API:polymer
mixtures. During manufacturing, powder flow and process
simulations may be carried out in advance to account for new
values of the API and excipient ratios that may for instance
Fig. 5 – NIR spectra of starting materials, polymer PEO and
the active compound (nitrofurantoin monohydrate, NFMH).
Fig. 6 – (a and b) The score surface image and loading of the first principal component; (c and d) the second principal
component. Extrudates A, B and C have varying ratios of NFMH:PEO: 30:70, 50:50 and 70:30, respectively.
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instigate different powder flow properties. Furthermore, moni-
toring and recording CQA (critical quality attributes) based on
chemical imaging PAT tools, such as NIR and Raman, can be
used to provide useful documentation of the product for the
regulatory authorities. At the final product level, chemical
imaging, dissolution and mechanical strength tests are re-
quired in order to validate the various simulations.
4. Conclusions
It has been demonstrated that in silico based product design
principles can be successfully applied to visualize both defor-
mation and stresses on extruded systems as well as to assess
the dissolution rate from the extruded product. Experimen-
tal investigations can be used to provide complimentary
information on the solid state properties, such as dehydra-
tion kinetics of the extruded product, and to establish themeans
for achieving continuous monitoring and production of the
product. In addition, rheological evaluation of molten polymer
based products is crucial in determining optimal HME pro-
cessing conditions. A computational approach combined with
experimental investigations conveys several advantages that
are indeed required in the pursuit of designing the futuremanu-
facturing solutions within the area of personalized medicine.
Finally, a PAT approach is a prerequisite for robust quality
control of personalized medicines.
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